Risk factors and prevention targets for abnormal cognitive aging

$164,429K24FY2017AGNIH

Vanderbilt University Medical Center, Nashville TN

Investigators

Linked publications & trials

Paper 39440670 Paper 39310215 Paper 39251807 Paper 38760857 Paper 38655188 Paper 38537892 Paper 38344221 Paper 38280312 Paper 37985223 Paper 37732479 Paper 37645973 Paper 37459083 Paper 37123017 Paper 37003129 Paper 36905877 Paper 36817413 Paper 36680854 Paper 36540999 Paper 36446680 Paper 35908327 Paper 35896049 Paper 35552371 Paper 35425899 Paper 35184795 Paper 34810243 Paper 34743630 Paper 34706559 Paper 34702069 Paper 34479171 Paper 34031194 Paper 33830999 Paper 33567862 Paper 33240156 Paper 33040257 Paper 32844198 Paper 32581762 Paper 32502831 Paper 32378327 Paper 32144980 Paper 32119589 Paper 31791659 Paper 31700989 Paper 31381510 Paper 31332262 Paper 31095735 Paper 30631339 Paper 30036759 Paper 30018169 Paper 29967939 Paper 29945917 Paper 29809069 Paper 29801024 Paper 29702372 Paper 29656011 Paper 29440034 Paper 29254087 Paper 29190651 Paper 29188888 Paper 29117962 Paper 28029271 Paper 27817134 Paper 27815399 Paper 27743375 Paper 27185022 Paper 26967211 Paper 26878034 Paper 26539829 Paper 26402085 Paper 26219209 Paper 26194614 Paper 26119224 Paper 25751166 Paper 25700178 Paper 25497326 Paper 25471188 Paper 25281602 Paper 25061054 Paper 24687776 Paper 24493370 Paper 23871264

Abstract

DESCRIPTION (provided by applicant): This proposal is a Midcareer Investigator Award in Patient-Oriented Research (K24) application for Angela Jefferson, PhD. Dr. Jefferson is a clinician-scientist whose interdisciplinary research program focuses on identification of early markers for mild cognitive impairment as well as hemodynamic factors contributing to the pathogenesis and clinical manifestation of Alzheimer's disease (AD). Dr. Jefferson is an Associate Professor of Neurology at Vanderbilt University Medical Center and the founding Director of the Vanderbilt Memory & Alzheimer's Center. In the 8 years since completing her training, Dr. Jefferson has demonstrated her commitment to professional education and mentorship and has established herself as a productive patient- oriented researcher in cognitive aging with strong NIH funding and a high-impact publication record. The proposed award will be instrumental in providing her protected time to expand her capabilities in cognitive aging patient-oriented research. In particular, she will gain new expertise and a practical skill set in the application of innovative biomarkers to better understand risk factors for accelerating the pathogenesis and clinical manifestation of AD. Furthermore, it will allow her to use her strong research program as a platform to mentor early career investigators, including graduate students, medical students, post-doctoral fellows, and junior faculty in patient-oriented research in cognitive aging. The proposal integrates the PI's interdisciplinary research team (including neuropsychology, cardiology, endocrinology, geriatrics, engineering, physics, neuroradiology, and biostatistics) with resources associated with the Vanderbilt Memory & Alzheimer's Center, the Vanderbilt University Institute of Imaging Science, and the Vanderbilt Institute for Clinical & Translational Research to offer a rich training environment for mentees. The training and research facilitated by this K24 mechanism will not only advance knowledge regarding early identification markers and vascular risk factors for AD, but it will also develop a cadre of next-generation cognitive aging researchers well-positioned to make meaningful contributions to the field.

View original record on NIH RePORTER →